TRI476 adjunctive therapy in children with inadequately controlled partial onset seizures

Phase 2, randomised, double-blind trial in Focal onset seizure comparing Trileptal adjunctive therapy with Placebo adjunctive therapy (2 arms). Primary endpoint: Percent change in partial onset seizure frequency per 28 days from baseline to the double-blind phase.